Oculis and EURETINA Announces the Ramin Tadayoni Award
June 27, 2024 06:30 ET
|
Oculis Holding AG
ZUG, Switzerland, June 27, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and...
Global Mint Essential Oils (Cornmint, Peppermint, Spearmint) Market Trends, Competitive Strategies and Forecasts, 2021-2023 & 2024-2031
June 27, 2024 06:30 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Mint Essential Oils Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Hut 8 Set to Join to Russell 3000® Index
June 27, 2024 06:30 ET
|
Hut 8 Corp.
Miami, June 27, 2024 (GLOBE NEWSWIRE) -- Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North...
Hut 8 Set to Join to Russell 3000® Index
June 27, 2024 06:30 ET
|
Hut 8 Corp.
MIAMI, June 27, 2024 (GLOBE NEWSWIRE) -- Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North...
Stallion Uranium Outlines 5 Conductive Trends as Key Target Areas on Sandy Lake Uranium Project
June 27, 2024 06:30 ET
|
Stallion Uranium Corp.
The completion of this survey has identified compelling target areas at Sandy Lake and takes the project another step closer to drill readiness
Global Rare Gas Market to reach a valuation of US$ 6.5 billion by 2034 | Future Market Insights, Inc.
June 27, 2024 06:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, June 27, 2024 (GLOBE NEWSWIRE) -- The global rare gas market will reach a valuation of US$ 3.9 billion in 2024, owing to the factors such as electrification of transportation. The trend...
X4 Pharmaceuticals Announces Positive Interim Clinical Data from Ongoing Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) and Initiation of Pivotal Phase 3 CN Trial
June 27, 2024 06:30 ET
|
X4 Pharmaceuticals
100% of evaluable participants at Month 6 achieved target absolute neutrophil count (ANC) increase with once-daily, oral mavorixafor +/- stable-dose G-CSF as of the interim analysis data cut-off date ...
Dividend Declaration
June 27, 2024 06:30 ET
|
WisdomTree Issuer ICAV
For Immediate Release: 27-Jun-24 WisdomTree Issuer ICAVRe: Dividend Payment The Directors of WisdomTree Issuer ICAV (the “Fund”) wish to...
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
June 27, 2024 06:30 ET
|
Medigene AG
Planegg/Martinsried, June 27, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Research 2023-2031: Stringent Regulatory Requirements, Growing Adoption of Personalized Medicine, Competition to Intensify
June 27, 2024 06:23 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key...